Breast cancer Flashcards
what is incidence of BRCA1 and 2?
1:300-800
- 10-20% of all ovarian and 5% breast cancers associated w/ BRCA 1/2.
BRCA1:
- breast cancer risk 70% (assoc w/ triple neg)
- ovarian cancer risk 40% - RRSO by 35-40
BRCA2
- breast cancer risk 70%
- ovarian cancer risk 20% (occurs later), RRSO by 40-45
- also incr risk prostate, pancreatic, gastric cancer, melanoma.
- ovarian cancers: endometrioid or high grade serous
- Chemoprophylaxis: OCPs to decrease ovarian cancer (decreases # of ovulations), tamoxifen to decrease breast cancer for BRCA2.
- RRSO reduces risk by 80%,, prophylactic mastectomy (decr risk by 90-95%).
What is screening for BRCA1/2?
CBE twice/year
- annual MRI at age 25
- annual mammogram and MRI at age 30, alternative q6mo
- ovarian cancer screening: not recommended! but consider CA-125, TVUS, pelvic yearly at age 30-35
- prophylactic mastectomy if done w/ childbearing/age 35)
- discuss chemoprophylaxis (only for BRCA2)
BRCA1 gene is located on chromosome 17
BRCA2 gene is located on chromosome 13
Who needs genetic counseling and screening?
- hx suggestive of AD cancer syndrome (eg Lynch)
- BRCA 1/2 mutation in family
- breast cancer < age 50
- breast cancer in male, ashkenazi Jew or triple neg hsitology
- person w/ multiple primary breast cancers
- concerning fam hx w/ multiple breast cancer, ovarian, pancreatic, prostate cancer
- any ovarian, fallopian tube or primary peritoneal cancer.
BRCA1/2 in general population: 1:300-1:800. In Ashkenazi Jews its 1:40
What are risk reducing strategies for high risk breast cancer?
Raloxifene - 60mg qd
- reduces ER pos breast cancer in POSTMENOPAUSAL
- cholesterol reduction
- incr VTE risk
- 60% reduction in breast cancer
- osteoporosis prevention and tx
- no time limit on tx.
Tamoxifen - BRCA2 carriers w/o mastectomy. reduces ER/PR pos, not good for BRCA1.
- cholesterol reduction, endometrial thickening, vTE risk.
- 50% reduction in breast cancer
- decrease fracture risk
- CAN ONLY USE FOR 10 YRS
-2.5x risk of EIN, geometrical cancer. minimal estrogenization.
What is the differential diagnosis of a breast mass in 30 y/o
- malignancy
- fibroadenoma
- breast cyst (simple or complex)
- fibrocystic changes
- breast abscess (if breastfeeding or sx mastitis)
- galatocele
- fat necrosis
How do you counsel pt with BRCA2?
- discuss incr risk breast cancer (85%) and ovarian cancer (20%).
- discuss risk of other cancers: melanoma, male breast cancer, prostate and pancreatic
- discuss breast cancer screening: CBE, mammogram and mRI
- discuss ovarian cancer screening: not strongly recommended. but Ca-125 and TVUS does not decrease mortality, can increase anxiety with false positives. Can do OCPs if still desires fertility. needs RRBSO by age 40-45
- chemoprophylaxis w/ tamoxifen (incr risk endometrial hyperplasia nd polyps)
Can you have HRT after a hysterectomy w/ BRCA1/2?
Yes, if no breast cancer can have estrogen alone.
What are benign breast lesions
- Non-proliferative
(1% incr risk future breast cancer)
Simple cysts
Mild hyperplasia (usual type)
Papillary apocrine change
What are benign breast lesions
- Proliferative w/o atypia AKA fibrocystic changes
(1.7% increased risk breast cancer)
1. Fibroadenoma (MOST COMMON CAUSE SOLID BREAST MASS)
——Benign proliferative breast lesions. Tumor w/ glandular and stromal tissues.
——-Risk factors: black race, age 20-30, OCP use before age 20
2 types: simple (no incr risk cancer) and complex (slightly increased risk of cancer. Small (1-2cm) firm well circumscribed mobile mass.
Ddx: US. well-circumscribed homogenous hyperdense lesion, mobile w/ probe. On mammogram - popcorn calcifications
Indications for biopsy?
- can biopsy or short term f/u (3-6mo) w/ repeat US + CBE.
- Size >2.5cm, enlarging, calcifications, pt peace of mind.
When to operate: if pain, concern for cancer, +fam hx breast cancer, questionable biospy results.
Giant fibroadenoma
2. Intraductal papilloma
Moderate hyperplasia
Sclerosing adenosis
Radial scar
What is Atypical hyperplasia?
(4% incr risk future breast cancer)
Atypical ductal hyperplasia
Atypical lobular hyerpplasia
What is Lobular carcinoma in situ
(7-10% incr risk future breast cancer)
What are categories of mastalgia and causes?
- Cyclical
- Non-cyclical
- Extramammary: costochondritis, chest wall trauma, rib fractures, fibromyalgia, herpes zoster, angina, GERD, pregnancy
Etiologies include mastitis, trauma, thrombophlebitis (Mondor disease), cysts, tumors and cancer. - Meds: hormonal meds, antidepressants, anti-HTN, antimicrobial
How is mastalgia evaluated?
- If assoc w/ breast cancer: more likely to be unilateral, intense, noncyclic and progressive
- CBE to identify discrete or concerning abnormalities and to evaluate chest wall separately from breast.
- Extrammary mastalgia: constochondritis c/w point tenderness over costochondral junction
- Duct ectasia, periductal mastitis and inflammatory conditions have mastalgia as primary symptom
- Breast imaging considered for focal mastalgia not explained by obvious cause (MSK) and if pain is new.
What is Mondor disease?
superficial thrombophlebitis of lateral thoracic vein - rare condition causes noncyclic breast pain/tenderness. PE=palpable cord (initial red and tender, linear skin dimpling). Need age appropriate breast imaging to r/o underlying cancer.
How is mastalgia managed?
Depends on source of pain. Reassurance if cyclic.
Non-pharmacologic: well fitted and supportive bras. Dietary changes.
Pharmacologic: NSAIDS=primary tx. OCPs NOT proven tx, can try continuous dosage to improve sx.
- Post-menopausaal women w/ mastalgia after initiating HRT can discontinue it or decrease estrogen dose.
If resistant: prescription meds for 3-6 months: Danazol - only fDA approved. Or tamoxifen (SERM) 10mg/day.
How is Duct ectasia diagnosed and managed?
Occurs in middle-aged and elderly. Smoking and parity=rF. Usually asymptomatic.
- Clinically as niple discharge, nipple inversion, noncyclic mastalgia or infxn. Doesn’t require surgery, manage conservatively.
What are Birads classification?
Birads 0- incomplete need additional imaging
Birads 1- neg (0% chance of malignancy)
Birads 2 - Benign (0% change of malignancy)
Birads 3 - probably benign 0-2% chance
Birads 4 - Suspicious. Categories a,b,c increasing likelihood f malignancy
Birads 5 - highly suggestive of malignancy >95%
Birads 6 - known biopsy proven malignancy.
**Lifetime risk of breast cancer is 12%!
screening protocol: age 40, annual or biannual (shared decision-making), annual CBE.